Real-time enrollment status for this breast cancer with low to intermediate her2 expression clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:07 PM UTC
| NCT Number | NCT07630402 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer With Low to Intermediate HER2 Expression |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Rochester |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 13, 2026: Clinical trial NCT07630402 is currently recruiting participants. This clinical trial study for breast cancer with low to intermediate her2 expression is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Rochester. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07630402 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07630402 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.